Vote in favour of Fortis-IHH deal, says proxy advisory firm

Proxy advisory firm ISS has recommended that Fortis Healthcare shareholders vote in favour of resolutions pertaining to the hospital chain’s proposed deal with Malaysian group IHH. ISS said the deal would help bring funds into the cash-strapped company and separate Fortis from ongoing issues that its erstwhile promoters Malvinder and Shivinder Singh are facing.

Fortis has called an extraordinary general meeting of shareholders to vote on the resolutions to facilitate the deal, which would see IHH infusing Rs 4,000 crore into the company and picking up a 31.1% stake. The proposal is to issue preferential shares to the investor. IHH would also have to make an open offer for 26% additional shares at Rs 170 each. As per the proposal, IHH would have rights to control two-thirds of the seats on the Fortis board.

ISS said the deal would “significantly” dilute existing public shareholding in Fortis to 68.28% from 99.26%. Following the open offer, the public shareholding could drop further. “Notwithstanding the potential dilution, the proposed issuance would provide the company necessary funds to finance its plans to improve its hospital business and to service its debt,” an ISS report said.
Shareholders will also be voting on a proposal to increase the authorised share capital of Fortis in order to facilitate issuance of new shares to IHH. They are also expected to vote on a proposal to declassify the Singh brothers as promoters of the company and name IHH subsidiary NTK Pvt Ltd in their place.

According to ISS, this would enable Fortis to “separate” itself from issues surrounding the current promoters and therefore shareholders should vote in favour of the move.

The Singhs have been embroiled in a legal battle with Daiichi Sankyo for several years over the enforcement of a Rs 3,500 crore arbitration award and the Japanese drug maker has been trying to block the Fortis-IHH deal in order to get its award from the brothers. Daiichi claims that Fortis and the Singhs are a “single economic entity” and therefore it has a right to recover its money through the company.

  • Related Posts

    CAHO Naa Patients Se Pyaar Hai

    Calcutta:  As Mishty Doi hit it off with over 2000 first rate delegates and healthcare’s quality crusaders from home and abroad, Patient safety resolve took center stage as never before…

    Ameera Shah, Prima Donna of Pathology, makes it to Powerful Healthcare Club NATHEALTH

    New Delhi:  She came, she saw and she conquered- This classic line aptly sums up the meteoric rise and shine of 44 year old Ameera Shah, Promoter &MD of Metropolis…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

    Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

    Significant Decline In Pharma Deals In Q1

    Significant Decline In Pharma Deals In Q1

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    Rise In AMR Is Leaving Doctors With Fewer Options In Drugs

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments

    CDSCO Releases Draft Guidance To Align New Drugs And Clinical Trials Rules And SUGAM For Stakeholder’s Comments